ASND — ASCENDIS PHARMA A/S
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 326 家机构在其最新 13F 申报中持有 ASND(ASCENDIS PHARMA A/S),合计申报市值 $18.33B,对应 69.84M 股。按股数计算较上季度减持 55.5%(-80.66M 股),申报市值环比上升 34.8%。持仓集中度较高:前五大持有人占申报市值的 44.5%,前十大的集中度为 62.4%。
与上一季度相比,84 家新建仓位、100 家加仓、105 家减仓、69 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
ASCENDIS PHARMA A/S(ASND)的主要机构持有人包括 Context Capital Management, LLC、RA CAPITAL MANAGEMENT, L.P.、T. Rowe Price Investment Management, Inc.,按 13F 申报市值在本页 603 家持有人中排名居前。
ASND 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
持有 ASND 的传奇投资人
我们追踪的超级投资人在各自最新 13F 申报中持有 ASND 的名单——每位投资人按其自身最近一个季度展示。
| 投资人 | 季度 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|---|
|
|
Q3 2026 | 21.86K | $4.98M | 0.05% | 新进 |
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 255 | 28.97M | $6.62B | -32.3% |
| Q2 2026 | 326 | 69.84M | $18.33B | -55.5% |
| Q1 2026 | 310 | 420.62M | $13.33B | +5.7% |
| Q4 2025 | 336 | 439.76M | $11.33B | +1.8% |
| Q3 2025 | 313 | 432.26M | $12.22B | +11.8% |
| Q2 2025 | 271 | 370.66M | $10.38B | -3.4% |
| Q1 2025 | 261 | 377.38M | $20.49B | -20.0% |
| Q4 2024 | 236 | 455.09M | $8.38B | +17.3% |
表内 8 个季度中,机构持股合计减少 94%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2026(-55.5%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 5.13M | $1.17B | 3.82% | 增持 | |
| 3.45M | $784.99M | 0.04% | 减持 | |
| 2.28M | $520.37M | 0.01% | 增持 | |
| 2.08M | $474.58M | 0.88% | 减持 | |
| 1.90M | $431.93M | 0.15% | 增持 | |
| 1.42M | $322.92M | 0.07% | 减持 | |
| 1.11M | $285.86M | 0.07% | 减持 | |
| 1.25M | $285.10M | 0.12% | 减持 | |
| 1.17M | $265.53M | 0.14% | 增持 | |
| 908.03K | $206.88M | 0.03% | 持有 | |
| 590.22K | $134.47M | 0.00% | 减持 | |
| 460.56K | $104.93M | 0.01% | 减持 | |
| 423.25K | $96.43M | 0.01% | 增持 | |
| 416.87K | $94.97M | 0.02% | 增持 | |
| 414.15K | $94.46M | 0.01% | 增持 | |
| 363.64K | $82.85M | 0.20% | 新进 | |
| 355.24K | $80.94M | 0.06% | 增持 | |
| 227.01K | $51.60M | 0.08% | 增持 | |
| 221.11K | $50.37M | 0.02% | 增持 | |
| 216.98K | $49.43M | 0.04% | 减持 | |
| 206.18K | $46.97M | 2.11% | 减持 | |
| 202.56K | $46.15M | 0.03% | 增持 | |
| 198.30K | $45.18M | 0.01% | 增持 | |
| 188.23K | $42.88M | 0.20% | 增持 | |
| 170.59K | $38.88M | 0.15% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
新建仓(Q2 2026)
- Jupiter Topco LLC 3.65M 股 · $973.38M
- GEODE CAPITAL MANAGEMENT, LLC 403.15K 股 · $107.53M
- Neuberger Berman Group LLC 142.71K 股 · $38.06M
- USS Investment Management Ltd 141.01K 股 · $37.63M
- VANGUARD PORTFOLIO MANAGEMENT LLC 103.54K 股 · $27.62M
- Fiera Capital Corp 103.31K 股 · $27.56M
- SAPIENT CAPITAL LLC 92.16K 股 · $24.58M
- ADAGE CAPITAL PARTNERS GP, L.L.C. 66.50K 股 · $17.74M
- ENVESTNET ASSET MANAGEMENT INC 45.78K 股 · $12.21M
- Eversept Partners, LP 41.62K 股 · $11.10M
- Quadrature Capital Ltd 40.84K 股 · $10.89M
- STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 33.38K 股 · $8.90M
完全清仓(较上季)
- NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 卖出 556.43K 股 · $127.27M
- WOLVERINE ASSET MANAGEMENT LLC 卖出 79.23M 股 · $116.26M
- DeepCurrents Investment Group LLC 卖出 49.89M 股 · $73.32M
- Point72 Asset Management 卖出 47.79M 股 · $70.48M
- Candriam S.C.A. 卖出 230.28K 股 · $52.67M
- CAPSTONE INVESTMENT ADVISORS, LLC 卖出 34.66M 股 · $50.97M
- Deutsche Bank AG 卖出 135.19K 股 · $30.92M
- Chevy Chase Trust Holdings, LLC 卖出 123.47K 股 · $28.24M
- Perpetual Ltd 卖出 100.64K 股 · $23.02M
- Troluce Capital Advisors LLC 卖出 99.60K 股 · $22.78M
- Boussard & Gavaudan Investment Management LLP 卖出 12.90K 股 · $18.83M
- STATE STREET CORP 卖出 12.45M 股 · $18.42M
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WESTFIELD CAPITAL MANAGEMENT CO LP | 5.13M | 4.80M | 4.81M | 5.19M | 5.26M | 5.45M | 5.48M | 5.53M | 5.13M | 4.96M | 4.08M | 4.03M | 3.80M | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 3.45M | 3.55M | 3.88M | 4.15M | 4.47M | 4.53M | 4.67M | 4.73M | 4.91M | 4.92M | 4.94M | 5.11M | 5.14M | 5.14M | 5.15M | 5.23M | 5.28M | 5.29M | 5.35M | 5.36M |
| BlackRock Inc | 2.28M | 2.21M | 9.18M | 7.28M | 5.53M | 5.62M | 5.97M | 6.10M | 5.05M | — | — | — | — | — | — | — | — | — | — | — |
| Artisan Partners Limited Partnership | 2.08M | 2.63M | 3.23M | 3.23M | 3.72M | 3.99M | 4.26M | 4.45M | 4.41M | 4.30M | 5.67M | 5.75M | 6.00M | — | — | — | — | — | — | — |
| MFS Investment Management | 1.90M | 1.88M | 1.86M | 1.89M | 1.88M | 1.90M | 1.88M | 1.87M | 1.87M | 1.71M | 1.62M | 1.52M | 1.26M | 1.09M | 1.36M | 1.34M | 1.18M | 835.20K | 770.93K | 752.30K |
| Capital International Investors | 1.42M | 1.99M | 1.96M | 3.06M | 3.06M | 3.05M | 2.87M | 2.86M | 2.11M | 2.10M | 2.19M | 2.18M | 2.17M | — | — | — | — | — | — | — |
| Franklin Resources | 1.11M | 1.86M | 47.32M | 47.32M | 47.35M | 47.88M | 47.88M | 47.88M | 47.69M | 47.53M | 46.51M | 42.50M | 42.50M | 42.50M | 1.35M | 1.38M | 1.15M | 958.04K | 921.68K | 919.41K |
| AMERICAN CENTURY COMPANIES INC | 1.25M | 1.40M | 1.40M | 1.44M | 544.61K | 530.81K | 462.17K | 407.29K | 346.75K | 305.97K | 306.14K | 307.74K | 13.87M | — | — | — | — | — | — | — |
| Principal Global Investors | 1.17M | 873.50K | 896.40K | 1.03M | 793.68K | 28.12K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Capital World Investors | 908.03K | 906.08K | 900.52K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 590.22K | — | 12.45M | 67.95K | 61.54K | 58.20K | 66.78K | 71.76K | 71.46K | 35.06K | 34.35K | 31.25K | 30.73K | — | — | — | — | — | — | — |
| Morgan Stanley | 460.56K | 544.39K | 2.89M | 2.19M | 3.95M | 5.90M | 996.00K | 5.37M | 5.37M | 166.97K | 1.75M | 4.62M | 3.42M | 2.52M | 133.22K | 82.94K | 171.46K | 196.35K | 106.68K | 63.57K |
| Geode Capital Management | 423.25K | 403.15K | 72.94K | 68.86K | 68.05K | 60.80K | 57.85K | 57.08K | 56.45K | 57.79K | 56.10K | 55.09K | 54.55K | 53.56K | 51.73K | 51.19K | 51.19K | 49.70K | 47.85K | 46.87K |
| BNY Mellon | 416.87K | 319.41K | 228.68K | 394.61K | 509.30K | 417.62K | 389.21K | 98.39K | 105.22K | 110.64K | 150.94K | 213.17K | 232.76K | 316.00K | 245.42K | 250.65K | 261.44K | 269.95K | 289.34K | 240.05K |
| JPMorgan Chase & Co | 414.15K | 367.78K | 696.00K | 2.22M | 458.00K | 492.00K | 185.12K | 77.43K | 39.83K | 617.26K | 28.01K | 61.86K | 2.25M | 25.00K | 75.00K | 76.74K | 91.12K | 124.21K | 3.00K | 17.28K |
| Chevy Chase Trust Holdings, LLC | 363.64K | — | 123.47K | 56.70K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity International (FIL) | 355.24K | 345.57K | 447.42K | 478.64K | 459.34K | 464.10K | 462.37K | 729.27K | 640.26K | 442.51K | 10.73K | 6.00K | — | — | 45.00K | 45.06K | — | — | — | — |
| Allspring Global Investments Holdings, LLC | 227.01K | 178.74K | 184.22K | 187.64K | 191.67K | 200.26K | 189.61K | 152.74K | 161.41K | 179.25K | 189.21K | 203.17K | 213.00K | — | — | — | — | — | — | — |
| Arrowstreet Capital | 221.11K | 125.77K | 91.47K | — | 60.66K | — | — | — | — | — | — | — | — | — | — | 29.22K | — | 13.11K | 2.02K | — |
| SEI INVESTMENTS CO | 216.98K | 237.87K | 351.15K | 281.47K | 205.32K | 236.57K | 258.01K | 263.58K | 273.75K | 264.57K | 346.19K | 361.83K | 396.44K | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold ASND?
As of 2026-Q2, 326 institutional funds reported holding ASND (ASCENDIS PHARMA A/S) in SEC 13F filings, with a combined reported value of $18.33B.
How many shares of ASND do institutions own?
13F filers reported 69.84M shares of ASND, worth $18.33B in aggregate at the end of 2026-Q2.
Is institutional ownership of ASND rising or falling?
Share counts moved -55.5% versus the prior quarter — distribution.
Who are the top institutional holders of ASND?
The largest 13F holders are Context Capital Management, LLC, RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, WESTFIELD CAPITAL MANAGEMENT CO LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of ASCENDIS PHARMA A/S?
The major shareholders of ASCENDIS PHARMA A/S (ASND) by reported 13F value are Context Capital Management, LLC, RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, among 603 institutional holders.
Which legendary investors own ASND?
1 of the legendary investors tracked on HoldingsHub report ASND (ASCENDIS PHARMA A/S) in their latest 13F filings, led by Polen Capital Management. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on ASND?
1 tracked superinvestors hold ASND simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.